Suppr超能文献

细菌衍生的细胞穿透肽递送庆大霉素以杀死细胞内病原体。

Bacterium-Derived Cell-Penetrating Peptides Deliver Gentamicin To Kill Intracellular Pathogens.

作者信息

Gomarasca Marta, F C Martins Thaynan, Greune Lilo, Hardwidge Philip R, Schmidt M Alexander, Rüter Christian

机构信息

Institute of Infectiology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Münster, Germany.

College of Veterinary Medicine, Kansas State University, Manhattan, Kansas, USA.

出版信息

Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02545-16. Print 2017 Apr.

Abstract

Commonly used antimicrobials show poor cellular uptake and often have limited access to intracellular targets, resulting in low antimicrobial activity against intracellular pathogens. An efficient delivery system to transport these drugs to the intracellular site of action is needed. Cell-penetrating peptides (CPPs) mediate the internalization of biologically active molecules into the cytoplasm. Here, we characterized two CPPs, α1H and α2H, derived from the YopM effector protein. These CPPs, as well as Tat (-activator of transcription) from HIV-1, were used to deliver the antibiotic gentamicin to target intracellular bacteria. The YopM-derived CPPs penetrated different endothelial and epithelial cells to the same extent as Tat. CPPs were covalently conjugated to gentamicin, and CPP-gentamicin conjugates were used to target infected cells to kill multiple intracellular Gram-negative pathogenic bacteria, including K1, serovar Typhimurium, and Taken together, CPPs show great potential as delivery vehicles for antimicrobial agents and may contribute to the generation of new therapeutic tools to treat infectious diseases caused by intracellular pathogens.

摘要

常用的抗菌药物细胞摄取能力较差,通常难以作用于细胞内靶点,导致对细胞内病原体的抗菌活性较低。因此,需要一种有效的递送系统将这些药物转运至细胞内作用位点。细胞穿透肽(CPPs)可介导生物活性分子内化进入细胞质。在此,我们对源自YopM效应蛋白的两种CPPs,即α1H和α2H进行了表征。这些CPPs以及来自HIV-1的Tat(转录激活因子)被用于将抗生素庆大霉素递送至细胞内的目标细菌。源自YopM的CPPs穿透不同内皮细胞和上皮细胞的程度与Tat相同。CPPs与庆大霉素共价偶联,CPP-庆大霉素偶联物用于靶向感染细胞以杀死多种细胞内革兰氏阴性病原菌,包括K1、鼠伤寒血清型和。总之,CPPs作为抗菌剂的递送载体具有巨大潜力,可能有助于开发新的治疗工具来治疗由细胞内病原体引起的传染病。

相似文献

引用本文的文献

4
Intracellular bacteria in cancer-prospects and debates.细胞内细菌与癌症——前景与争议
NPJ Biofilms Microbiomes. 2023 Oct 9;9(1):76. doi: 10.1038/s41522-023-00446-9.

本文引用的文献

1
Cell-Penetrating Bacterial Effector Proteins: Better Tools than Targets.穿膜细菌效应蛋白:比靶标更好的工具。
Trends Biotechnol. 2017 Feb;35(2):109-120. doi: 10.1016/j.tibtech.2016.08.002. Epub 2016 Sep 1.
5
Cell-penetrating peptides transport therapeutics into cells.细胞穿透肽将治疗剂输送到细胞内。
Pharmacol Ther. 2015 Oct;154:78-86. doi: 10.1016/j.pharmthera.2015.07.003. Epub 2015 Jul 22.
9
Current activities of the Yersinia effector protein YopM.耶尔森氏菌效应蛋白YopM的当前活性
Int J Med Microbiol. 2015 May;305(3):424-32. doi: 10.1016/j.ijmm.2015.03.009. Epub 2015 Apr 1.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验